lnfliximab dose intensification in 17-years old patients with Crohn's disease
Journal Title: Pediatria Współczesna. Gastroenterologia, Hepatologia i Żywienie Dziecka - Year 2007, Vol 9, Issue 3
Abstract
nfliximab is recommended for the treatment of sever, active Crohn's disease (CD) in pediatrie and adolescent patients, who have not responded to conventional therapy. Case report of 17-years old boy with celiac disease and sever CD (A1, L3+L4, B3p) diagnosed at ten ye-ars of age is presented. During the third year of maintenance therapy he lost response to interval of infliximabu infusion. Clinical response was regained after dose intensification by decreasing in interval from eight to four weeks between infliximab infusions. After three months of the intensive treatment with infliximab, patient still remains in clinical remission.
Authors and Affiliations
Małgorzata Sładek
Immunohistochemical and morphometric study of duodenal biopsies from school-aged children with a previous history of cow's milk allergy
Introduction: Adverse reactions to food that result in gastrointestinal symptoms are common in infancy. Recently formal evidence have been found that cow's milk protein sensitive enteropathy may persist in older children...
Alergia na białko pokarmowe
Assessment of the nutritional status in 7 to 10 year-old children from Podlasie region
Introduction: The proper nutritional status of children enables their growth and development. Overweight and obesity as well as malnutrition are hazardous for children's health. Aim of study: Assessment of the nutritiona...
Chronic abdominal pain in children
Except for infectious diseases abdominal pain is the most frequent complain in childhood. In this review functional abdominal pain is de-scribed which is defined as chronić pain not related to structural and biochemical...
Wpływ choroby refluksowej przełyku na występowanie nawracających infekcji dróg oddechowych oraz astmy oskrzelowej u dzieci w wieku szkolnym
Wprowadzenie: W ostatnich latach coraz większą rolę w obrazie klinicznym choroby refluksowej przełyku odgrywają objawy pozaprzełykowe, a szczególnie objawy pochodzące z układu oddechowego. Cel pracy: Określenie rodzaju...